mustafa kamal



Pakistan eyes joint vaccine, pharma production with China amid looming funding crunch

  • Health minister says Pakistan imports 80–90 percent of pharmaceutical raw materials
  • Officials warn vaccine costs could rise to $1.2 billion annually after donor support ends by 2030
By Waseem Abbasi ·